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Abstract
Na-dependent neutral amino acid transport into the bovine renal epithelial cell line NBL-1 is catalysed by a broad-
specificity transporter originally termed System B0. This transporter is shown to differ in specificity from the B0 transporter
cloned from JAR cells [J. Biol. Chem. 271 (1996) 18657] in that it interacts much more strongly with phenylalanine. Using
probes designed to conserved transmembrane regions of the ASC/B0 transporter family we have isolated a cDNA encoding
the NBL-1 cell System B0 transporter. When expressed in Xenopus oocytes the clone catalysed Na-dependent alanine
uptake which was inhibited by glutamine, leucine and phenylalanine. However, the clone did not catalyse Na-dependent
phenylalanine transport, again as in NBL-1 cells. The clone encoded a protein of 539 amino acids; the predicted
transmembrane domains were almost identical in sequence to those of the other members of the B0/ASC transporter family.
Comparison of the sequences of NBL-1 and JAR cell transporters showed some differences near the N-terminus,
C-terminus and in the loop between helices 3 and 4. The NBL-1 B0 transporter is not the same as the renal brush border
membrane transporter since it does not transport phenylalanine. Differences in specificity in this protein family arise from
relatively small differences in amino acid sequence. ß 2002 Elsevier Science B.V. All rights reserved.
Keywords: Amino acid; Transport; Broad speci¢city; Sodium dependence; NBL-1; ASC; B0
1. Introduction
Na-dependent neutral amino acid transport into
mammalian cells is mediated by System A and/or by
one or more of a family of broad-speci¢city trans-
porters which have been termed System ASC or Sys-
tem B0 (see, e.g., [1] for a review). These transport
activities are di¡erentiated by the fact that System A
takes N-methylaminoisobutyrate (MeAIB) as a sub-
strate while the others do not. The term System ASC
describes a transport activity which recognises only
small aliphatic amino acids, and excludes glutamine,
branched chain amino acid and phenylalanine. Ala-
nine transport via System ASC is inhibited by gluta-
mate and aspartate at pH 5.5. The term System B0
was originally applied to the broad-speci¢city trans-
porter in the bovine renal epithelial cell line NBL-1
[2] This di¡ers from System ASC in that alanine
transport is competitively inhibited by glutamine,
leucine and phenylalanine, but is not inhibited by
glutamate and aspartate at pH 5.5. A similar activity
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has been described in JAR cells [3]. Phenylalanine
and leucine are not themselves transported by System
B0 in NBL-1 cells, although they are good inhibitors
of alanine transport.
In the past few years a number of clones have been
isolated which, when expressed heterologously cata-
lyse Na-dependent broad-speci¢city neutral amino
acid transport activity. The ¢rst of these was ASCT1
[4,5], which was later shown to catalyse a Na-de-
pendent obligatory antiport of amino acids and to
have chloride channel activity [6]. Utsonomiya-Tate
et al. [7] isolated a further ASC clone, designated
ASCT2, which catalysed electroneutral Na-depen-
dent obligatory antiport of amino acids and was sug-
gested to correspond to System ASC. The ¢rst Sys-
tem B0-like transporter (ATB0) was cloned from the
human choriocarcinoma cell line JAR [8]. Finally,
Kekuda et al. cloned another broad-speci¢city trans-
porter from rabbit intestine [9]. This was a brush
border membrane protein [10] with broad speci¢city.
Alanine uptake by this transporter was inhibited by
glutamate and aspartate at pH 5.5, but this clone
also has been termed ATB0 [9]
ASCT1, ASCT2, ATB0 from JAR cells and the
rabbit intestinal transporter are all closely related
members of a family of mammalian Na-dependent
broad-speci¢city transporters which is part of the
glutamate transporter superfamily. However, little
is known about the structural basis of the di¡erences
in amino acid speci¢city between these various trans-
porters. In order to attempt to address this question,
we report here the cloning of the broad-speci¢city
transporter from NBL-1 cells which was originally
designated as System B0. This is of interest because
preliminary experiments in our laboratory had al-
ready shown some di¡erences in speci¢city between
alanine uptake into NBL-1 cells and into JAR cells
via System B0 transporters.
2. Materials and methods
2.1. Materials
All reagents were obtained from Sigma (Poole,
Dorset, UK) unless otherwise stated. Radiolabelled
L-[2,3-3H]alanine and L-phenyl-[2,3-3H]alanine were
from Amersham (Amersham, UK).
2.2. Cell culture
Cell lines were cultured in Hams F12 nutrient me-
dium (Gibco, Paisley, UK) supplemented with 10%
(v/v) foetal bovine serum, antibiotics (100 U/ml pen-
icillin G, 0.1 mg/ml streptomycin) and 2 mM gluta-
mine prior to use. Cells were routinely trypsinised
and seeded onto 35-mm Petri dishes for experiments.
The cells were fed every other day until con£uent,
typically after 4 days.
2.3. Measurement of amino acid uptake by
cell monolayers
Uptake of amino acids into cell lines was measured
at room temperature in the presence of 0.5 mM ami-
no-oxyacetate to inhibit alanine metabolism as de-
scribed by Doyle and McGivan [2].
2.4. Screening of an NBL-1 cell cDNA library
A commercial NBL-1 cell lambda-Zap II bacterio-
phage cDNA library (Stratagene, Cambridge, UK)
was screened according to manufacturer’s instruc-
tions. Brie£y, appropriate cDNA fragments (see re-
sults) were radiolabelled using the ‘Redi-prime’
cDNA labelling kit (Amersham) and [K-32P]dCTP
(ICN, Basingstoke, UK) according to the manufac-
turer’s directions. Filters were prehybridised for 4 h
and hybridised to radiolabelled cDNA probes over-
night at 60‡C in a bu¡er containing 6U SSC (1U
SSC contains 150 mM NaCl, 15 mM sodium citrate,
pH 7.0), 5U Denhardt’s reagent (1% Ficoll (type
400), 1% polyvinylpyrrolidone and 1% BSA), 0.2%
SDS and 50 Wg/ml sonicated salmon sperm DNA.
Filters were subsequently washed three times in 1U
SSC, 0.1% SDS at room temperature and a further
three times in 0.5U SSC, 0.1% SDS at 50‡C prior to
autoradiography. Positive clones were subjected to
further rounds of screening prior to excision and
subsequent culture according to manufacturers’ in-
structions.
2.5. Transporter expression in oocytes
Isolation of Xenopus laevis oocytes and expression
of NBL-1 cell B0 mRNA in this system was per-
formed essentially as described previously [11]. Oo-
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cytes were maintained at 18‡C in modi¢ed Barth’s
medium (89 mM NaCl, 1 mM KCl, 0.42 mM
MgSO4, 0.84 mM NaHCO3, 0.82 mM CaCl2, 5
mM HEPES (pH 7.6), 5 mM sodium pyruvate, 50
Wg/ml gentamycin (Fluka)) after type II collagenase
separation and manual defollication. Healthy stage V
and VI oocytes were selected for microinjection with
either 50 ng of cRNA (T7 mMessage mMachine in
vitro transcription kit, Ambion) encoding the trans-
porter or water as a control. Oocytes were then used
in transport assays 4 days post injection.
2.6. Oocyte amino acid uptake experiments
Oocytes (minimum of ¢ve per data point) were
washed for 1 min at room temperature in the appro-
priate incubation medium (either 95 mM NaCl or 95
mM LiCl with 2 mM KCl, 0.82 mM MgCl2, 1 mM
CaCl2 and 20 mM Tris^HEPES at pH 7.4). This
medium was then changed for one supplemented
with the required concentration of unlabelled sub-
strate spiked with 0.5 mCi/ml of 3H-labelled sub-
strate, as indicated in the legends to the ¢gures. Up-
take was terminated by ¢ve sequential washes in ice-
cold uptake medium, prior to lysis of single oocytes
in scintillation vials with 100 Wl SDS (2% w/v), addi-
tion of scintillation £uid (Emulsi¢er Safe, Packard)
and liquid scintillation counting for 10 min/vial
(Canberra Packard 4430 Series, Berkshire, UK).
3. Results and discussion
3.1. Comparison of alanine uptake into NBL-1 cells
and JAR cells
The initial rate of alanine uptake into both cell
lines was linear with time over 5 min and was ob-
served to be 90% sodium dependent (results not
shown). Uptake of alanine was measured in the pres-
ence of a 100-fold excess of single unlabelled amino
acids. Alanine uptake was not signi¢cantly inhibited
by the system A substrate MeAIB nor by the charged
amino acids glutamate, aspartate and lysine in either
cell line. Glutamine and to a lesser extent leucine
inhibited sodium dependent alanine uptake into
both cell lines. However, phenylalanine was a more
potent inhibitor of alanine uptake into NBL-1 cells
than into JAR cells (Table 1). Fig. 1 shows the e¡ect
of phenylalanine concentration on the initial rate of
alanine uptake into both cell lines. Phenylalanine was
a weak inhibitor of alanine transport into JAR cells
but was more e¡ective in NBL-1 cells. These direct
comparisons of phenyalanine inhibition of alanine
transport are consistent with previous reports. Thus
phenylalanine competitively inhibited Na-depen-
dent alanine transport (100 WM) into NBL-1 cells
with a Ki of approximately 4 mM [2] whereas the
IC50 for the inhibition of 2.5 nM alanine uptake
into JAR cells by phenylalanine was 16.9 mM [3].
In neither cell line was alanine transport inhibited
by glutamate and aspartate at pH 5.5 (results not
shown).
3.2. Cloning of NBL-1 cell B0
Two pairs of oligonucleotide primers were de-
signed to conserved transmembrane spanning regions
Fig. 1. Inhibition of Na-dependent alanine uptake by phenyla-
lanine in NBL-1 and JAR cells. The initial rate of Na-depen-
dent uptake of 0.1 mM alanine by con£uent monolayer cultures
of NBL-1 cells (a) and JAR cells (b) was measured at room
temperature after 3 min in the presence of 0.5 mM amino-oxy-
acetate. Phenylalanine was present at the concentrations shown.
The results are presented as a percentage of the uninhibited
rate which was 0.94 þ 0.09 nmol/mg protein per min for NBL-1
cells and 1.51 þ 0.12 nmol/min per mg protein for JAR cells.
Results shown are the overall means obtained from two or
more experiments for each phenylalanine concentration and in-
dividual values for each experimental point were the means of
three Petri dishes. S.E.M.s (not shown) were less than 10% of
the mean value in each case.
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of a multiple sequence alignment of ASCT1, ASCT2
and the JAR cell B0 (not shown). These primer pairs,
designated F1/R1 and F2/R2 were used in reverse
transcription^polymerase chain reactions (RT^PCR)
on NBL-1 cell total RNA in order to amplify two
fragments of NBL-1 cell B0. The resulting PCR
products (of 400 and 370 bp, respectively) were li-
gated into pGEM T-Easy (Promega) and used to
transform CaCl2-competent E. coli. Plasmid DNA
was extracted (Qiaprep spin kit, Qiagen) and sub-
jected to automated sequencing (Applied Biosystems,
Warrington, UK) using vector-speci¢c M13 primers
to con¢rm the identity of the PCR fragments.The
primers used were as follows. F1: 5P-CCA TCA
TGG TGG CCG ATC CTC-3P ; F2: 5P-CTG CTC
TTT TTC CTG GTC ACC AC-3P ; R1: 5P-GTG
GTG ACC AGG AAA AAG AGC AG-3P ; R2:
5P-AGG AGT TGA AGA AGC GAA TGA GCA
GC-3P.
These radiolabelled PCR fragments were subse-
quently used to screen 800 000 plaques of a lamb-
da-Zap II bacteriophage NBL-1 cDNA library as
described above. One full-length 2.9 kb clone was
detected by both probes and subsequently sequenced
in its entirety. Fig. 2 shows the nucleotide sequence
Fig. 2. Full-length cDNA sequence and derived amino acid se-
quence for System B0 from NBL-1 cells. This sequence has
been submitted to GenBank (accession no. AY039236).
Table 1
Inhibition pro¢le of alanine uptake into NBL-1 cells and JAR
cells
Inhibiting amino acid Initial rate of alanine uptake (%
of control)
NBL-1 cells JAR cells
None 100 100
Lysine 82 þ 5.5 96 þ 4
MeAIB 97 þ 3 98 þ 4
Serine 7 þ 31 10 þ 3
Glutamine 10 þ 4 5 þ 3
Glutamate 87 þ 7 91 þ 4
Leucine 40 þ 3.5 43 þ 2
Phenylalanine 54 þ 5 89 þ 2*
Aspartate 90 þ 6 97 þ 4.5
The initial rate of Na-dependent alanine uptake into con£uent
monolayer cultures of NBL-1 and JAR cells was measured after
3 min. Alanine was present at 50 WM and inhibitory amino
acids were added at 5 mM. Rates are shown as the percentage
of the rates in the absence of inhibitor which were 0.83 þ 0.04
nmol/min per mg protein for NBL-1 cells and 1.6 þ 0.11 nmol/
min per mg protein for JAR cells. Results are the means
þ S.E.M. for triplicate Petri dishes. *P6 0.05 vs. NBL-1 cells.
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and derived amino acid sequence of this clone. The
putative transporter clone was 2892 bp in length pos-
sessing an open reading frame of 539 amino acids.
3.3. Expression of the NBL-1 transporter in
Xenopus oocytes
In order to characterise the properties of alanine
transport into oocytes expressing the NBL-1 B0 clone
alanine was used at 50 WM ^ the same concentration
as used in the cell experiments. The initial rate of
sodium dependent alanine (50 WM) uptake into B0
cRNA-injected oocytes was linear with time over 30
min. Fig. 3 shows that the initial rate of 50 WM
alanine transport in sodium-containing medium was
approximately 20 times greater for B0 cRNA injected
oocytes than their water-injected or non-injected
counterparts. In order to determine the extent to
which transport was Na-dependent, the experiments
were repeated in a medium where Na was replaced
by an equal concentration of Li. This resulted in a
smaller induction of alanine transport.
The e¡ects of high concentrations of single unla-
belled amino acids on the initial uptake of 50 WM
alanine into NBL-1 B0 cRNA-injected oocytes were
tested (Table 2). Glutamine, serine, leucine and phe-
nylalanine inhibited alanine uptake, whilst lysine and
Me-AIB had no e¡ect. Fig. 4 shows concentration
dependence of the inhibition of alanine transport
by phenylalanine in NBL-1 B0 cRNA-injected oo-
cytes. These results are consistent with inhibition
data in NBL-1 cells. In further experiments, it was
shown that NBL-1 B0 cRNA injection into oocytes
did not induce any signi¢cant uptake of radiolabelled
phenylalanine in the presence of sodium (results not
shown).
Table 2
Inhibition pro¢le of alanine uptake into NBL-1 B0 cRNA-in-
jected Xenopus oocytes
Inhibiting amino acid Initial rate of alanine uptake (% of
control)
None (control) 100.0
Glutamine 30.5 þ 0.7**
Serine 0.5 þ 0.8**
Leucine 13.9 þ 2.6**
Phenylalanine 56.1 þ 8.0*
Lysine 81.8 þ 9.9
MeAIB 93.7 þ 11.5
The e¡ects of a 100-fold excess of single unlabelled amino acids
(5 mM) on the sodium-dependent uptake of alanine (50 WM)
into NBL-1 B0 cRNA-injected oocytes were tested. Rates as de-
termined from a minimum of ¢ve oocytes per experiment are
shown as a percentage of the control rate in the absence of in-
hibiting amino acids (mean þ S.E.M.) which was found to be
78 þ 7 pmol/oocyte per 25 min. Rates were corrected for the up-
take measured in water-injected oocytes. *P6 0.05 vs. control,
**P6 0.001 vs. control.
Fig. 4. Inhibition of alanine transport by phenylalanine in oo-
cytes injected with NBL-1 System B0 cRNA. The initial rate of
uptake of alanine (25 WM) was measured after 25 min in Na-
containing medium in the presence of the concentrations of
phenylalanine shown. Each value is the mean of ¢ve oocytes.
Fig. 3. Uptake of alanine (50 WM) into Xenopus oocytes. Oo-
cytes were injected with NBL-1 B0 cRNA or H2O and uptake
of alanine was measured in the presence of Na- or Li-con-
taining medium after 25 min as described in Section 2. Results
are the mean þ S.E.M. of at least ¢ve oocytes for each point.
Results are expressed as a percentage of the rate with cRNA-in-
jected oocytes in the Na medium which was 86 þ 6 pmol/oo-
cyte per 25 min. NI, non-injected.
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These kinetic characteristics of alanine transport
catalysed by oocytes expressing NBL-1 B0 are very
similar to those of System B0 originally reported in
NBL-1 cells. In both cases alanine uptake was ob-
served to be largely sodium dependent and was in-
hibited by small aliphatic amino acids, leucine and
phenylalanine, but not by Me-AIB or lysine. This
relatively strong inhibition by phenylalanine is a dis-
tinctive feature of this NBL-1 cell broad-speci¢city
transporter which di¡erentiates it from the weak in-
hibition observed in JAR cells. Although phenylala-
nine was an inhibitor of the NBL-1 System B0 trans-
porter in injected oocytes these oocytes did not
catalyse phenylalanine uptake. Similarly phenylala-
nine was not transported into NBL-1 cells by a
Na-dependent process [2]. It appears that phenyl-
alanine may compete with alanine for the substrate
binding site but once bound, cannot be transported.
Similar behaviour has been observed for the intesti-
nal peptide transporter where 4-aminomethylbenzoic
acid acts as a competitive inhibitor of peptide trans-
port but is not itself a substrate [11]. However, it is
clear that the B0 clones from JAR cells and NBL-1
cells do not correspond to the Na-dependent broad-
speci¢city amino acid transporter activity located in
renal brush border membranes, for which phenylala-
nine and leucine are good substrates. Indeed, System
B0 in NBL-1 cells is predominantly expressed on the
basolateral membrane when these cells are grown as
con£uent monolayers on ¢lters [2].
3.4. Sequence comparison with other
B0/ASC transporters
Fig. 5 shows a multiple alignment of the derived
amino acid sequences of rat ASCT2, the JAR cell
clone, the NBL-1 B0 clone described in this paper
and the rabbit intestinal clone which has also been
termed B0. All these clones are similar in length. The
ten predicted transmembrane domains are nearly
Fig. 5. Amino acid sequence alignment of some broad-speci¢city amino acid transporters. The sequences shown are: rASCT2, rat
ASCT2 [12], GenBank AJ132846; JAR B0, JAR cell B0 [8], GenBank U53347; NBL-1 B0, this paper, GenBank AY039236; Rabint,
rabbit intestine B0 [9], GenBank U75284. Sequences were aligned using the ClustalW multiple sequence alignment program. Assign-
ments of transmembrane regions are taken from [9] and are shown in bold.
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identical in sequence between the four clones and
the overall sequences are closely similar. Thus the
clone from NBL-1 cells shows similarities of 82.6%,
87.7% and 88.3% at the amino acid level and 78%,
84.8% and 84% at the DNA level with rat ASCT2,
JAR cell B0 and rabbit intestine B0. respectively. A
comparison of the NBL-1 clone reported here with
the B0-clone from JAR cells shows some di¡erences
in the N-terminal region between amino acids 19
and 35, di¡erences in the loop region between heli-
ces 3 and 4 and some di¡erences also in the C-ter-
minal domain. Some of these di¡erences in amino
acid sequence are presumably responsible for the
di¡erence in a⁄nity of phenylalanine as an inhibitor
between these clones. Di¡erences in sequence be-
tween the B0 and ASCT2 clones also occur mainly
in these regions, and there are also quite large di¡er-
ences in these regions between individual ASCT2
clones isolated from mouse, human and rat sources
(not shown).
This family of Na-dependent broad-speci¢city
transporters encompasses a spectrum of proteins
showing progression from limited to much wider
substrate speci¢city. The ASCT2 clone catalyses the
obligatory exchange of small amino acids but ex-
cludes glutamine, branched chain amino acids and
phenylalanine. Transport of alanine is inhibited by
glutamate and aspartate at pH 5.5. Alanine transport
catalysed by the NBL-1 and JAR B0 clones is inhib-
ited by glutamine, leucine and phenylalanine. Inhibi-
tion by phenylalanine is much stronger for the NBL-
1 clone than for the JAR cell clone. Transport by
these B0 clones is not a¡ected by glutamate and as-
partate at pH 5.5.
The rabbit intestinal clone shows rather di¡erent
properties. This transports amino acids in a strongly
electrogenic manner, and has a broad speci¢city. It
interacts with branched chain and aromatic amino
acids although direct evidence for transport of these
amino acids is lacking. However, it also di¡ers from
the NBL-1 and JAR B0 clones in that it does interact
with glutamate and aspartate at pH 5.5. This clone
may well encode the major brush border amino acid
transporter involved in intestinal amino acid absorp-
tion [9], and may represent a di¡erent sub-family
from the B0 transporters in NBL-1 cells and JAR
cells. The overall nomenclature of this broad-speci-
¢city transporter family may require some revision.
All these di¡erences in speci¢city arise as a result
of relatively subtle changes in amino acid sequence
and little information about structure^function rela-
tionships can be derived simply from an inspection of
sequence di¡erences. In particular, it is not possible
to deduce any structural features which di¡erentiate
ASCT2 from B0 transporters. It is possible that site-
directed mutagenesis or domain-swapping experi-
ments based on these sequences may eventually
shed more light on the molecular basis of substrate
speci¢city in this transporter family.
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